Dermopigmentation of the nipple-areola complex in a dedicated breast cancer centre, following the Treviso Hospital (Italy) LILT model.


Journal

Annali dell'Istituto superiore di sanita
ISSN: 2384-8553
Titre abrégé: Ann Ist Super Sanita
Pays: Italy
ID NLM: 7502520

Informations de publication

Date de publication:
Historique:
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 3 11 2021
Statut: ppublish

Résumé

Dermopigmentation, also known as medical tattooing, is a complementary technique in the reconstruction of the nipple-areola and an adjuvant procedure to improve colour mismatch. In 2009, tattooing of the nipple-areola complex (NAC) was introduced by Treviso Hospital through a project conducted in cooperation with the local section of the Italian Anti-Cancer League (LILT). From 2010 to 2016, 169 patients treated for breast cancer underwent dermopigmentation treatments. Patients were selected by the hospital plastic and breast surgeons. Dermopigmentation was performed at the LILT (Lega Italiana per la Lotta contro i Tumori, Italian Cancer League) facility following a specific procedure to ensure safety. A sterile disposable surgical set was used. Of 169 patients treated in 309 treatment sessions, no serious complications were reported after tattooing, with only three cases seen of minor complications. Patients expressed a high level of satisfaction (90%) with the aesthetic results. The study found that dermopigmentation of the NAC is a safe approach, providing benefits both to the patients and the hospital itself. Medical tattooing of the NAC is a simple and safe nonsurgical technique that reduces missed workdays and increases the time available for other commitments. This ultimately translates into savings for society and the healthcare system.

Sections du résumé

BACKGROUND BACKGROUND
Dermopigmentation, also known as medical tattooing, is a complementary technique in the reconstruction of the nipple-areola and an adjuvant procedure to improve colour mismatch. In 2009, tattooing of the nipple-areola complex (NAC) was introduced by Treviso Hospital through a project conducted in cooperation with the local section of the Italian Anti-Cancer League (LILT).
METHODS METHODS
From 2010 to 2016, 169 patients treated for breast cancer underwent dermopigmentation treatments. Patients were selected by the hospital plastic and breast surgeons. Dermopigmentation was performed at the LILT (Lega Italiana per la Lotta contro i Tumori, Italian Cancer League) facility following a specific procedure to ensure safety. A sterile disposable surgical set was used.
RESULTS RESULTS
Of 169 patients treated in 309 treatment sessions, no serious complications were reported after tattooing, with only three cases seen of minor complications. Patients expressed a high level of satisfaction (90%) with the aesthetic results.
CONCLUSION CONCLUSIONS
The study found that dermopigmentation of the NAC is a safe approach, providing benefits both to the patients and the hospital itself. Medical tattooing of the NAC is a simple and safe nonsurgical technique that reduces missed workdays and increases the time available for other commitments. This ultimately translates into savings for society and the healthcare system.

Identifiants

pubmed: 33346170
doi: 10.4415/ANN_20_04_06
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-451

Auteurs

Alessandro Gava (A)

Radioterapia Oncologica, Ospedale di Treviso, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy.

Antonia Pirrera (A)

Centro Nazionale per le Tecnologie Innovative in Sanità Pubblica, Istituto Superiore di Sanità, Rome, Italy.

Alessandra De Dominicis (A)

Centro Nazionale per la Ricerca e la Valutazione Preclinica e Clinica dei Farmaci, Istituto Superiore di Sanità, Rome, Italy.

Rita Molinaro (R)

Expert consultant in medical tattooing for LILT, Treviso, Italy.

Alessandra Lepri (A)

Centro Nazionale per la Ricerca e la Valutazione Preclinica e Clinica dei Farmaci, Istituto Superiore di Sanità, Rome, Italy.

Carmine Guarino (C)

USMAF-SASN Ministero della Salute, Rome, Italy.

Christian Rizzetto (C)

Chirurgia Senologica-Breast Unit, Ospedale di Treviso, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy.

Giorgio Berna (G)

Dipartimento di Chirurgia Plastica, Ospedale di Treviso, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy.

Alberto Renzoni (A)

Centro Nazionale per le Tecnologie Innovative in Sanità Pubblica, Istituto Superiore di Sanità, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH